Balchem Corporation Cash Flow Conversion Efficiency
Balchem Corporation cash flow conversion efficiency. Based on the latest financial reports, Balchem Corporation (BCPC) has a cash flow conversion efficiency ratio of 0.031x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($40.06 Million) by net assets ($1.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Balchem Corporation (1989–2025)
Cash flow conversion efficiency of Balchem Corporation from 1989 to 2025. This chart illustrates how Balchem Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Balchem Corporation stock price for real-time trading data and today's change.
Balchem Corporation Cash Flow Conversion Ratio Explained
Balchem Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Balchem Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Balchem Corporation ranked by their cash flow conversion efficiency. Also see Balchem Corporation market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIGMASTAR TECH LTD
SHE:301536
|
0.029x |
|
Guangzhou Automobile Group Co Ltd Class A
SHG:601238
|
0.003x |
|
INTERCORP FIN.SERV. O.N.
F:9IFA
|
0.217x |
|
EVN AG
VI:EVN
|
-0.007x |
|
Intercorp Financial Services Inc
NYSE:IFS
|
-0.008x |
|
Almonty Industries Inc
AU:AII
|
-0.035x |
|
LB Group Co Ltd
SHE:002601
|
0.037x |
|
TEMENOS AG UNSP.ADR/1
F:TE8A
|
0.282x |
Annual Cash Flow Conversion Efficiency for Balchem Corporation (1989–2025)
The table below shows the annual cash flow conversion efficiency of Balchem Corporation from 1989 to 2025. Review BCPC free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.26 Billion | $216.56 Million | 0.172x | +8.81% |
| 2024-12-31 | $1.15 Billion | $182.00 Million | 0.158x | -9.22% |
| 2023-12-31 | $1.05 Billion | $183.76 Million | 0.174x | +18.08% |
| 2022-12-31 | $938.28 Million | $138.54 Million | 0.148x | -19.33% |
| 2021-12-31 | $877.01 Million | $160.51 Million | 0.183x | +0.73% |
| 2020-12-31 | $828.23 Million | $150.49 Million | 0.182x | +8.57% |
| 2019-12-31 | $743.67 Million | $124.46 Million | 0.167x | -2.48% |
| 2018-12-31 | $691.62 Million | $118.70 Million | 0.172x | -4.29% |
| 2017-12-31 | $616.88 Million | $110.62 Million | 0.179x | -13.18% |
| 2016-12-31 | $521.03 Million | $107.61 Million | 0.207x | -7.76% |
| 2015-12-31 | $463.70 Million | $103.83 Million | 0.224x | +2.81% |
| 2014-12-31 | $391.90 Million | $85.35 Million | 0.218x | +29.58% |
| 2013-12-31 | $331.36 Million | $55.69 Million | 0.168x | -14.68% |
| 2012-12-31 | $273.01 Million | $53.78 Million | 0.197x | +1.79% |
| 2011-12-31 | $232.01 Million | $44.90 Million | 0.194x | -7.04% |
| 2010-12-31 | $187.47 Million | $39.03 Million | 0.208x | -36.27% |
| 2009-12-31 | $147.14 Million | $48.07 Million | 0.327x | +63.38% |
| 2008-12-31 | $114.51 Million | $22.90 Million | 0.200x | +19.03% |
| 2007-12-31 | $93.08 Million | $15.64 Million | 0.168x | -22.66% |
| 2006-12-31 | $75.36 Million | $16.37 Million | 0.217x | -3.37% |
| 2005-12-31 | $60.93 Million | $13.70 Million | 0.225x | -7.02% |
| 2004-12-31 | $50.23 Million | $12.14 Million | 0.242x | -13.76% |
| 2003-12-31 | $39.78 Million | $11.15 Million | 0.280x | -7.78% |
| 2002-12-31 | $33.27 Million | $10.11 Million | 0.304x | +139.02% |
| 2001-12-31 | $25.33 Million | $3.22 Million | 0.127x | -58.17% |
| 2000-12-31 | $19.58 Million | $5.95 Million | 0.304x | +15.79% |
| 1999-12-31 | $17.90 Million | $4.70 Million | 0.263x | +6.37% |
| 1998-12-31 | $15.80 Million | $3.90 Million | 0.247x | +1.20% |
| 1997-12-31 | $12.30 Million | $3.00 Million | 0.244x | -36.31% |
| 1996-12-31 | $9.40 Million | $3.60 Million | 0.383x | +77.13% |
| 1995-12-31 | $7.40 Million | $1.60 Million | 0.216x | -32.86% |
| 1994-12-31 | $5.90 Million | $1.90 Million | 0.322x | +228.47% |
| 1993-12-31 | $5.10 Million | $500.00K | 0.098x | -26.47% |
| 1992-12-31 | $4.50 Million | $600.00K | 0.133x | -51.11% |
| 1991-12-31 | $4.40 Million | $1.20 Million | 0.273x | +0.91% |
| 1990-12-31 | $3.70 Million | $1.00 Million | 0.270x | -16.22% |
| 1989-12-31 | $3.10 Million | $1.00 Million | 0.323x | -- |
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment… Read more